NET Cancer Day is celebrated annually on November 10th, worldwide! What is NET Cancer? What are neuroendocrine tumors? Neuroendocrine tumors (NETs) is the umbrella term for a group of unusual cancers which develop from cells in the diffuse endocrine system. NETs can affect people of any age, and can be slow-growing or very aggressive. They are found most commonly in the lung or gastrointestinal system, but they can also originate

NET Cancer Day is celebrated annually on November 10th, worldwide! Let’s start thinking about NET Cancer Day and plan for this years upcoming event! What is NET Cancer? What are neuroendocrine tumors? Neuroendocrine tumors (NETs) is the umbrella term for a group of unusual cancers which develop from cells in the diffuse endocrine system. NETs can affect people of any age, and can be slow-growing or very aggressive. They are found

NET Cancer Day is celebrated annually on November 10th, worldwide! What is NET Cancer? What are neuroendocrine tumors? Neuroendocrine tumors (NETs) is the umbrella term for a group of unusual cancers which develop from cells in the diffuse endocrine system. NETs can affect people of any age, and can be slow-growing or very aggressive. They are found most commonly in the lung or gastrointestinal system, but they can also originate

NET Cancer Day is celebrated annually on November 10th, worldwide! Let’s start thinking about NET Cancer Day and plan for this years upcoming event! What is NET Cancer? What are neuroendocrine tumors? Neuroendocrine tumors (NETs) is the umbrella term for a group of unusual cancers which develop from cells in the diffuse endocrine system. NETs can affect people of any age, and can be slow-growing or very aggressive. They are found

Lexicon Pharmaceuticals invites you to attend a Live National Webcast with Leigh Ann Burns, a registered oncology dietician from Oshsner-Kenner Neuroendocrine Tumor Clinic in Louisiana. She will be discussing the unique challenges presented in the diets of neuroendocrine cancer patients, particularly in dealing with Carcinoid Syndrome. This 45-minute live Webcast will include a presentation as well as a Q&A session where our presenter will address audience questions. You will have the